Acetaminophen in the treatment of headaches associated with dipyridamole-aspirin combination

被引：15

作者：

Lipton, RB

Bigal, ME

Kolodner, KB

Gorelick, PB

Wilks, K

Schoebelock, M

Davidai, G

机构：

[1] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA

[2] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA

[3] Rush Med Coll, Dept Neurol, Chicago, IL 60612 USA

[4] New England Ctr Headache, Stamford, CT USA

[5] AdvancePCS, Hunt Valley, MD USA

[6] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA

来源：

NEUROLOGY | 2004年 / 63卷 / 06期

关键词：

D O I：

10.1212/01.WNL.0000138494.66691.07

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The authors assessed the prevalence of headaches following extended-release dipyridamole/aspirin combination (DAC), and the efficacy of acetaminophen in the treatment of these headaches. Following DAC, 38.7% of the participants developed headaches. The headaches were self-limited (69.4% placebo efficacy in 2 hours) and the incidence markedly declined over time. Acetaminophen was no more effective than placebo in the acute and preemptive treatment of these headaches.

引用

页码：1099 / 1101

页数：3

共 8 条

[1] European stroke prevention study .2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke [J].